Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Protocolized Magnesium Replacement in Critically Ill Patients on Mortality and Atrial Fibrillation: the MAGNOLIA Randomized Controlled Trial

NCT07173855 is registered in ClinicalTrials.gov with Scarborough General Hospital as lead sponsor.

NCT NCT07173855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07173855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Protocolized Magnesium Replacement in Critically Ill Patients on Mortality and Atrial Fibrillation: the MAGNOLIA Randomized Controlled Trial
Lead sponsor
Scarborough General Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
November 25, 2025
Completion date
June 1, 2027
Enrollment
3,853 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness